{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "notwithstanding-anything-to-the-contrary", "type": "clause", "offset": [0, 40]}, {"key": "article-7", "type": "definition", "offset": [49, 58]}, {"key": "neither-party-shall", "type": "clause", "offset": [60, 79]}, {"key": "right-to-make", "type": "clause", "offset": [89, 102]}, {"key": "election-under", "type": "clause", "offset": [106, 120]}, {"key": "cooperative-research", "type": "definition", "offset": [125, 145]}, {"key": "technology-enhancement", "type": "clause", "offset": [150, 172]}, {"key": "act-of-2004", "type": "definition", "offset": [173, 184]}, {"key": "consent-of-the", "type": "clause", "offset": [306, 320]}, {"key": "other-party", "type": "clause", "offset": [321, 332]}, {"key": "with-respect-to", "type": "clause", "offset": [334, 349]}, {"key": "the-parties-shall", "type": "clause", "offset": [379, 396]}, {"key": "other-activities", "type": "clause", "offset": [470, 486]}, {"key": "the-parties-acknowledge-and-agree-that", "type": "clause", "offset": [507, 545]}, {"key": "this-agreement", "type": "clause", "offset": [546, 560]}, {"key": "joint-research-agreement", "type": "clause", "offset": [567, 591]}, {"key": "the-create-act", "type": "clause", "offset": [607, 621]}], "samples": [{"hash": "8XQXSot3AyX", "uri": "/contracts/8XQXSot3AyX#create-act", "label": "Exclusive License Agreement (Ablynx NV)", "score": 28.7508563995, "published": true}, {"hash": "hxGqSiI7F5T", "uri": "/contracts/hxGqSiI7F5T#create-act", "label": "Exclusive License Agreement (Ablynx NV)", "score": 28.6605072021, "published": true}, {"hash": "7oTwcsEW75j", "uri": "/contracts/7oTwcsEW75j#create-act", "label": "Exclusive License Agreement (Ablynx NV)", "score": 28.6057491302, "published": true}], "snippet": "Notwithstanding anything to the contrary in this Article 7, neither Party shall have the right to make an election under the Cooperative Research and Technology Enhancement Act of 2004, 35 U.S.C. 103(c)(2)-(c)(3) (the \u201cCREATE Act\u201d) when exercising its rights under this Article 7 without the prior written consent of the other Party. With respect to any such permitted election, the Parties shall coordinate their activities with respect to any submissions, filings, or other activities in support thereof. The Parties acknowledge and agree that this Agreement is a \u201cjoint research agreement\u201d as defined in the CREATE Act.", "size": 45, "hash": "fa5fb8d47d62535fd46ef3fa261a85f8", "id": 1}, {"snippet_links": [{"key": "notwithstanding-anything-to-the-contrary", "type": "clause", "offset": [0, 40]}, {"key": "article-8", "type": "definition", "offset": [49, 58]}, {"key": "neither-party", "type": "definition", "offset": [60, 73]}, {"key": "right-to-make", "type": "clause", "offset": [88, 101]}, {"key": "election-under", "type": "clause", "offset": [105, 119]}, {"key": "cooperative-research", "type": "definition", "offset": [124, 144]}, {"key": "technology-enhancement", "type": "clause", "offset": [149, 171]}, {"key": "act-of-2004", "type": "definition", "offset": [172, 183]}, {"key": "consent-of-the", "type": "clause", "offset": [307, 321]}, {"key": "other-party", "type": "clause", "offset": [322, 333]}, {"key": "with-respect-to", "type": "clause", "offset": [400, 415]}, {"key": "the-parties-will", "type": "clause", "offset": [445, 461]}, {"key": "reasonable-efforts-to-cooperate", "type": "clause", "offset": [466, 497]}, {"key": "other-activities", "type": "clause", "offset": [574, 590]}, {"key": "the-parties-acknowledge-and-agree-that", "type": "clause", "offset": [611, 649]}, {"key": "this-agreement", "type": "clause", "offset": [650, 664]}, {"key": "joint-research-agreement", "type": "clause", "offset": [671, 695]}, {"key": "the-create-act", "type": "clause", "offset": [711, 725]}], "samples": [{"hash": "b7xhnxmHZEn", "uri": "/contracts/b7xhnxmHZEn#create-act", "label": "Collaboration and License Agreement", "score": 26.1444225311, "published": true}, {"hash": "dD10JSz0mAA", "uri": "/contracts/dD10JSz0mAA#create-act", "label": "Collaboration and License Agreement (Regulus Therapeutics Inc.)", "score": 25.1587944031, "published": true}, {"hash": "aMOpmtelPSL", "uri": "/contracts/aMOpmtelPSL#create-act", "label": "Collaboration and License Agreement (Regulus Therapeutics Inc.)", "score": 23.6255989075, "published": true}], "snippet": "Notwithstanding anything to the contrary in this Article 8, neither Party will have the right to make an election under the Cooperative Research and Technology Enhancement Act of 2004, 35 U.S.C. \u00a7 103(c)(2)-(c)(3) (the \u201cCREATE Act\u201d) when exercising its rights under this Article 8 without the prior written consent of the other Party, which will not be unreasonably withheld, conditioned or delayed. With respect to any such permitted election, the Parties will use reasonable efforts to cooperate and coordinate their activities with respect to any submissions, filings or other activities in support thereof. The Parties acknowledge and agree that this Agreement is a \u201cjoint research agreement\u201d as defined in the CREATE Act.", "size": 31, "hash": "a67f8cfa5b4a093f721c20d6c2a591da", "id": 2}, {"snippet_links": [{"key": "the-parties", "type": "clause", "offset": [0, 11]}, {"key": "to-qualify", "type": "clause", "offset": [38, 48]}, {"key": "benefits-of", "type": "clause", "offset": [57, 68]}, {"key": "cooperative-research", "type": "definition", "offset": [73, 93]}, {"key": "technology-enhancement", "type": "clause", "offset": [98, 120]}, {"key": "each-party", "type": "clause", "offset": [167, 177]}, {"key": "further-consideration", "type": "clause", "offset": [208, 229]}, {"key": "the-request", "type": "clause", "offset": [243, 254]}, {"key": "other-party", "type": "clause", "offset": [262, 273]}, {"key": "necessary-for", "type": "definition", "offset": [360, 373]}, {"key": "the-create-act", "type": "clause", "offset": [440, 454]}], "samples": [{"hash": "l2g4kjO1JeL", "uri": "/contracts/l2g4kjO1JeL#create-act", "label": "Collaborative Research, Development, Commercialization and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "7o1p4zmE9fC", "uri": "/contracts/7o1p4zmE9fC#create-act", "label": "Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc)", "score": 29.6187534332, "published": true}, {"hash": "1JVi5bSNM9f", "uri": "/contracts/1JVi5bSNM9f#create-act", "label": "Collaborative Research, Development, Commercialization and License Agreement (Senomyx Inc)", "score": 29.1806983948, "published": true}], "snippet": "The parties intend for this Agreement to qualify for the benefits of the Cooperative Research and Technology Enhancement (CREATE) Act (35 U.S.C. 103(c)). Accordingly, each party agrees, without demanding any further consideration therefor, at the request of the other party, to do (and cause its employees to do) all lawful and just acts that may be or become necessary for evidencing, maintaining, recording and perfecting the benefits of the CREATE Act.", "size": 14, "hash": "ddb90e9f21b4846dba3be8e4abec00b0", "id": 7}, {"snippet_links": [{"key": "this-agreement", "type": "clause", "offset": [34, 48]}, {"key": "joint-research-agreement", "type": "clause", "offset": [55, 79]}, {"key": "as-amended", "type": "definition", "offset": [129, 139]}, {"key": "cooperative-research", "type": "definition", "offset": [147, 167]}, {"key": "technology-enhancement", "type": "clause", "offset": [172, 194]}, {"key": "the-provisions-of", "type": "clause", "offset": [219, 236]}, {"key": "agree-to", "type": "clause", "offset": [275, 283]}, {"key": "reasonable-actions", "type": "definition", "offset": [306, 324]}, {"key": "safe-harbor-provisions", "type": "definition", "offset": [405, 427]}], "samples": [{"hash": "5EwaeM4cXgj", "uri": "/contracts/5EwaeM4cXgj#create-act", "label": "Research Collaboration and License Agreement (Atrium Therapeutics, Inc.)", "score": 37.0793991089, "published": true}, {"hash": "bSQ5oKQ0LWf", "uri": "/contracts/bSQ5oKQ0LWf#create-act", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 33.9746742249, "published": true}, {"hash": "b8Mb6HjAPBB", "uri": "/contracts/b8Mb6HjAPBB#create-act", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 32.6851463318, "published": true}], "snippet": "It is the Parties\u2019 intention that this Agreement is a \u201cjoint research agreement\u201d as that phrase is defined in 35 U.S.C. \u00a7 102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. \u00a7 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products under such safe harbor provisions.", "size": 29, "hash": "e395e59251228e2b9affd6c3ad988849", "id": 4}, {"snippet_links": [{"key": "the-intention-of-the-parties", "type": "clause", "offset": [6, 34]}, {"key": "this-agreement", "type": "clause", "offset": [40, 54]}, {"key": "joint-research-agreement", "type": "clause", "offset": [61, 85]}], "samples": [{"hash": "f0gfXfivcnd", "uri": "/contracts/f0gfXfivcnd#create-act", "label": "License and Collaboration Agreement", "score": 35.7160072327, "published": true}, {"hash": "boOy8QHPF5d", "uri": "/contracts/boOy8QHPF5d#create-act", "label": "License Agreement (Gemini Therapeutics, Inc. /DE)", "score": 33.6680374146, "published": true}, {"hash": "cGj1bpiqpB6", "uri": "/contracts/cGj1bpiqpB6#create-act", "label": "Collaboration, Option and License Agreement (Vividion Therapeutics, Inc.)", "score": 32.3073234558, "published": true}], "snippet": "It is the intention of the Parties that this Agreement is a \u201cjoint research agreement\u201d as that phrase is defined in 35 USC \u00a7103(c)(3).", "size": 29, "hash": "b98ba3ac095522b3061fce7eef935f1a", "id": 3}, {"snippet_links": [{"key": "this-agreement", "type": "clause", "offset": [0, 14]}, {"key": "joint-research-agreement", "type": "clause", "offset": [26, 50]}], "samples": [{"hash": "bCHJALEwVZM", "uri": "/contracts/bCHJALEwVZM#create-act", "label": "License Agreement (Biodelivery Sciences International Inc)", "score": 29.2409305573, "published": true}, {"hash": "ghiUUAwHLoZ", "uri": "/contracts/ghiUUAwHLoZ#create-act", "label": "License Agreement (Biodelivery Sciences International Inc)", "score": 28.8548946381, "published": true}, {"hash": "gS5T7keWmHc", "uri": "/contracts/gS5T7keWmHc#create-act", "label": "License and Collaboration Agreement (Zealand Pharma a/S)", "score": 28.5099239349, "published": true}], "snippet": "This Agreement includes a joint research agreement as defined in 35 U.S.C. \u00a7 103(c)(3).", "size": 11, "hash": "1aa71ea8ae0fb0d1dfb0c91f6aedbce7", "id": 9}, {"snippet_links": [{"key": "notwithstanding-anything-to-the-contrary", "type": "clause", "offset": [0, 40]}, {"key": "in-this-agreement", "type": "definition", "offset": [41, 58]}, {"key": "each-party-will", "type": "clause", "offset": [60, 75]}, {"key": "right-to-invoke", "type": "clause", "offset": [85, 100]}, {"key": "cooperative-research", "type": "definition", "offset": [105, 125]}, {"key": "technology-enhancement", "type": "clause", "offset": [130, 152]}, {"key": "act-of-2004", "type": "definition", "offset": [153, 164]}, {"key": "article-v", "type": "clause", "offset": [247, 256]}, {"key": "consent-of-the", "type": "clause", "offset": [302, 316]}, {"key": "other-party", "type": "clause", "offset": [317, 328]}, {"key": "such-party", "type": "clause", "offset": [336, 346]}, {"key": "the-create-act", "type": "clause", "offset": [365, 379]}, {"key": "notify-the", "type": "clause", "offset": [389, 399]}, {"key": "with-respect-to", "type": "clause", "offset": [493, 508]}, {"key": "other-activities", "type": "clause", "offset": [537, 553]}, {"key": "the-parties-acknowledge-and-agree-that", "type": "clause", "offset": [574, 612]}, {"key": "joint-research-agreement", "type": "clause", "offset": [633, 657]}], "samples": [{"hash": "d8k8heotZfA", "uri": "/contracts/d8k8heotZfA#create-act", "label": "License Agreement (Apogee Therapeutics, Inc.)", "score": 37.4709091187, "published": true}, {"hash": "bazNzwMkyyw", "uri": "/contracts/bazNzwMkyyw#create-act", "label": "License Agreement (Jade Biosciences, Inc.)", "score": 37.1752243042, "published": true}, {"hash": "bZexS67RMej", "uri": "/contracts/bZexS67RMej#create-act", "label": "License Agreement (Jade Biosciences, Inc.)", "score": 37.1752243042, "published": true}], "snippet": "Notwithstanding anything to the contrary in this Agreement, each Party will have the right to invoke the Cooperative Research and Technology Enhancement Act of 2004, 35 U.S.C. \u00a7 103(c)(2)-(c)(3) (the \u201cCREATE Act\u201d) when exercising its rights under Article V of this Agreement, without the prior written consent of the other Party. Where such Party intends to invoke the CREATE Act, it will notify the other Party and the other Party will cooperate and coordinate its activities with such Party with respect to any submissions, filings or other activities in support thereof. The Parties acknowledge and agree that this Agreement is a joint research agreement (JRA) as defined in the CREATE Act.", "size": 18, "hash": "be69a29c8ff8b1262b47673c93ef3064", "id": 6}, {"snippet_links": [{"key": "licensee-shall", "type": "clause", "offset": [0, 14]}, {"key": "cooperative-research", "type": "definition", "offset": [30, 50]}, {"key": "technology-enhancement", "type": "clause", "offset": [55, 77]}, {"key": "act-of-2004", "type": "definition", "offset": [78, 89]}, {"key": "united-states-code", "type": "clause", "offset": [142, 160]}, {"key": "with-respect-to", "type": "clause", "offset": [181, 196]}, {"key": "patent-rights", "type": "clause", "offset": [201, 214]}, {"key": "consent-of", "type": "clause", "offset": [257, 267]}], "samples": [{"hash": "lECbIVBKnm7", "uri": "/contracts/lECbIVBKnm7#create-act", "label": "Exclusive Option Agreement (Kairos Pharma, LTD.)", "score": 34.7412719727, "published": true}, {"hash": "jA2ilTQmCPw", "uri": "/contracts/jA2ilTQmCPw#create-act", "label": "Exclusive License Agreement (Kairos Pharma, LTD.)", "score": 34.7412719727, "published": true}, {"hash": "eARFk0KBI9o", "uri": "/contracts/eARFk0KBI9o#create-act", "label": "Exclusive Option Agreement (Kairos Pharma, LTD.)", "score": 34.7412719727, "published": true}], "snippet": "Licensee shall not invoke the Cooperative Research and Technology Enhancement Act of 2004, as set forth under Title 35, Section 102(c) of the United States Code (the \u201cCREATE Act\u201d), with respect to the Patent Rights without first obtaining the prior written consent of CSMC.", "size": 19, "hash": "f0a35c5bbc41365549caadad59c4afd2", "id": 5}, {"snippet_links": [{"key": "the-parties-agree", "type": "clause", "offset": [0, 17]}, {"key": "this-agreement", "type": "clause", "offset": [43, 57]}, {"key": "joint-research-agreement", "type": "clause", "offset": [73, 97]}, {"key": "cooperative-research", "type": "definition", "offset": [130, 150]}, {"key": "technology-enhancement", "type": "clause", "offset": [155, 177]}, {"key": "act-of-2004", "type": "definition", "offset": [178, 189]}, {"key": "in-the-event-of", "type": "clause", "offset": [276, 291]}, {"key": "the-parties-will", "type": "clause", "offset": [308, 324]}, {"key": "the-create-act", "type": "clause", "offset": [358, 372]}, {"key": "patent-application", "type": "definition", "offset": [456, 474]}], "samples": [{"hash": "aoPQXJ1yqSp", "uri": "/contracts/aoPQXJ1yqSp#create-act", "label": "Sponsored Research Agreement", "score": 33.1959877014, "published": true}, {"hash": "ykwKt9UCCw", "uri": "/contracts/ykwKt9UCCw#create-act", "label": "Sponsored Research Agreement", "score": 31.8975296021, "published": true}, {"hash": "9ExA99uWP6I", "uri": "/contracts/9ExA99uWP6I#create-act", "label": "Sponsored Research Agreement", "score": 31.615398407, "published": true}], "snippet": "The Parties agree by marking this box that this Agreement constitutes a \u201cjoint research agreement\u201d as that term is defined by the Cooperative Research and Technology Enhancement Act of 2004, pre-America Invents Act (\u201cAIA\u201d) 35 U.S.C. \u00a7 103(c) and/or AIA USC 102(c) and 100(h). In the event of any Inventions, the Parties will reasonably cooperate in invoking the CREATE Act and its companion regulations to overcome an obviousness or novelty rejection of a patent application.", "size": 12, "hash": "34f4f9646662c79b08089ea5b5579291", "id": 8}, {"snippet_links": [{"key": "purposes-of-the", "type": "clause", "offset": [8, 23]}, {"key": "cooperative-research", "type": "definition", "offset": [24, 44]}, {"key": "technology-enhancement", "type": "clause", "offset": [49, 71]}, {"key": "act-of-2004", "type": "definition", "offset": [72, 83]}, {"key": "the-parties-agree-that", "type": "clause", "offset": [85, 107]}, {"key": "this-agreement", "type": "clause", "offset": [108, 122]}, {"key": "joint-research-agreement", "type": "clause", "offset": [143, 167]}], "samples": [{"hash": "lakAt6k1ICu", "uri": "/contracts/lakAt6k1ICu#create-act", "label": "Unilateral Non Disclosure Agreement", "score": 33.3848648071, "published": true}, {"hash": "7sq67Pi77pi", "uri": "/contracts/7sq67Pi77pi#create-act", "label": "Unilateral Non Disclosure Agreement", "score": 33.190612793, "published": true}, {"hash": "9NMB6L4B0lt", "uri": "/contracts/9NMB6L4B0lt#create-act", "label": "Non Disclosure Agreement", "score": 30.3053283691, "published": true}], "snippet": "For the purposes of the Cooperative Research and Technology Enhancement Act of 2004, the parties agree that this Agreement is not considered a joint research agreement.", "size": 10, "hash": "263581f0b25430cb154eeb90f8374c51", "id": 10}], "next_curs": "ClMSTWoVc35sYXdpbnNpZGVyY29udHJhY3Rzci8LEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhNjcmVhdGUtYWN0IzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"parents": [["intellectual-property", "Intellectual Property"], ["patent-prosecution", "Patent Prosecution"], ["miscellaneous", "Miscellaneous"], ["maintenance-and-prosecution-of-patents", "Maintenance and Prosecution of Patents"], ["patent-rights", "Patent Rights"]], "title": "CREATE Act", "size": 410, "children": [["governing-law", "Governing Law"], ["severability", "Severability"], ["use-of-names", "Use of Names"], ["relationship-of-the-parties", "Relationship of the Parties"], ["limitation-of-liability", "Limitation of Liability"]], "id": "create-act", "related": [["hire-act", "HIRE Act", "HIRE Act"], ["\u2587\u2587\u2587\u2587\u2587\u2587-act", "\u2587\u2587\u2587\u2587\u2587\u2587 Act", "\u2587\u2587\u2587\u2587\u2587\u2587 Act"], ["\u2587\u2587\u2587\u2587\u2587-act", "\u2587\u2587\u2587\u2587\u2587 Act", "\u2587\u2587\u2587\u2587\u2587 Act"], ["federal-power-act", "Federal Power Act", "Federal Power Act"], ["authorization-contravention", "Authorization; Contravention", "Authorization; Contravention"]], "related_snippets": [], "updated": "2026-07-04T04:24:40+00:00", "also_ask": ["What are the essential elements that must be included in a CREATE Act clause to ensure enforceability?", "How can parties strategically leverage the CREATE Act in joint research agreements to maximize IP protection?", "What are the most common pitfalls or fatal flaws in drafting CREATE Act provisions?", "How does the CREATE Act interact with other patent law doctrines, such as joint inventorship or prior art exclusions?", "What are the key judicial interpretations or tests that courts apply when assessing CREATE Act claims?"], "drafting_tip": "Cite the full statutory name and effective date to ensure precision; reference relevant sections to clarify obligations; define key terms to avoid misinterpretation.", "explanation": "The CREATE Act clause refers to provisions that address the rights of joint inventors from different organizations when collaborating on federally funded research. It typically allows inventions made under a joint research agreement to be treated as if they were made by a single entity for patent purposes, provided certain conditions are met, such as a written agreement and disclosure of the collaboration. This clause facilitates collaborative innovation by clarifying patent ownership and reducing legal barriers that might otherwise prevent effective joint research and development."}, "json": true, "cursor": ""}}